official notice
decision of a delegate of the commissioner of patents
Application : No. 675938 in the name of OraVax Inc
Title: Oral Treatment of Helicobacter Infection
Action: Opposition under section 59 by CSL Limited Request Application for dismissal under Regulation 5.5 by OraVax Inc
Decision: Issued .
Abstract
Request for dismissal refused. Particulars relating to novelty, obviousness, manner of manufacture and S40 were found to be adequate.
patents act 1990
decision of a delegate of the commissioner of patents
Re: Patent Application No. 675938 by OraVax Inc and Opposition under section 59 by CSL Limited and a Request for dismissal under Regulation 5.5 by OraVax Inc
background
Patent application 675938 was advertised accepted on 27 February 1997 and a notice of opposition was filed on 27 May 1997 by CSL Limited. On 27 August 1997, the opponent filed a statement of grounds and particulars in support of their opposition. On 29 September 1997 the applicant filed an application for dismissal of the opposition. On the 3 December 1997, the delegate proposed a direction be given that the opponent must file further and better particulars for grounds 1 to 3 to the opposition. On the 17 December 1997, the opponent made a written submission on the application for dismissal and the proposed direction. Subsequently on the 7 January 1998, the delegate decided not to give the proposed direction in the light of the opponent’s submissions. A hearing was set down for 20 March 1998. Neither party attended and each requested that the Delegate take into account their respective written submissions.
The Statement of Grounds and Particulars
The Grounds of Opposition on which the Opponent relies are that the alleged invention of Application No. 675938 is not novel, is obvious and does not involve an inventive step and is not a manner of manufacture within the meaning of Section 6 of the Statute of Monopolies and that the complete specification of Application No. 675938 does not comply with Section 40(2) or (3) of the Act.
Under the joint particular of novelty, inventive step and manner of manufacture, 13 documents were listed. Each document listed had a one sentence explanation of its relevance. A typical example is as follows:
“Document A: Czinn, S.J. and Carr, H.S. (1989). Pediatr. Res., 25:176A. this document discloses production of a gastrointestinal immune response following oral immunization with Campylobacter (now Helicobacter) pylori.”
The particulars also contain; a statement that the invention is a mere collocation of known integers, a description of the common general knowledge in the art, 10 particularisations of S40 matters, and a statement contesting the priority date of the application.
Request for dismissal
General Submissions
The applicant in their letter of 29 September 1997 referred to a number prior decisions of the Patents Office:- DuPont v DowElanco (1994) AIPC 91-067, Commonwealth Scientific and Industrial Research Organisation v Cem Corporation (1994) 29 IPR 72 and Mobay Corporation v The Dow Chemical Company 24 IPR 379 - as authority for the proposition…
Keep reading for free
Create a free CaseChat account to read Ora Vax Inc v CSL Limited and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1998] APO 18
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.